Anti-TNF compounds
US10208310B2 · kind B2 · utility
16Cited by
18References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2015 |
| Grant date | Feb 19, 2019 |
| Priority date | — |
| Expiry date | Oct 6, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or disorders using the TNFα antisense oligonucleotides and related products are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.